PORACTANT ALFA

PORACTANT ALFA was reported 737 times

PORACTANT ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEONATAL PNEUMOTHORAX 18 0.3273
1 PULMONARY HAEMORRHAGE NEONATAL 28 0.3043
2 NEONATAL HYPOXIA 121 0.1463
3 RESPIRATORY TRACT HAEMORRHAGE NEONATAL 1 0.1429
4 NEONATAL INTESTINAL PERFORATION 5 0.1389
5 PANTOEA AGGLOMERANS TEST POSITIVE 1 0.1250
6 CARDIO-RESPIRATORY ARREST NEONATAL 9 0.1154
7 ENDOTRACHEAL INTUBATION COMPLICATION 39 0.0661
8 END-TIDAL CO2 DECREASED 3 0.0638
9 HAEMORRHAGE NEONATAL 3 0.0577
10 NEONATAL RESPIRATORY FAILURE 28 0.0553
11 MENINGITIS NEONATAL 3 0.0545
12 NEONATAL PNEUMONIA 12 0.0511
13 BRONCHITIS PNEUMOCOCCAL 1 0.0476
14 LISTERIA TEST POSITIVE 1 0.0455
15 LATE METABOLIC ACIDOSIS OF NEWBORN 1 0.0417
16 BRADYCARDIA NEONATAL 51 0.0405
17 MECONIUM PERITONITIS 1 0.0400
18 CONGENITAL EMPHYSEMA 1 0.0385
19 CYANOSIS NEONATAL 24 0.0374
20 INFANTILE APNOEA 30 0.0368
21 PREMATURE BABY DEATH 3 0.0366
22 CARDIAC ARREST NEONATAL 5 0.0362
23 DRUG-DEVICE INTERACTION 4 0.0360
24 AIRWAY PEAK PRESSURE INCREASED 5 0.0329
25 DISSEMINATED INTRAVASCULAR COAGULATION IN NEWBORN 1 0.0323
26 NEONATAL ANURIA 3 0.0316
27 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 15 0.0309
28 ENTERITIS NECROTICANS 1 0.0278
29 BRONCHOPULMONARY DYSPLASIA 20 0.0248
30 NECROTISING ENTEROCOLITIS NEONATAL 10 0.0246
31 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 3 0.0211
32 TRACHEAL INJURY 3 0.0204
33 RENAL FAILURE NEONATAL 4 0.0180
34 HYPOXIC ISCHAEMIC ENCEPHALOPATHY NEONATAL 1 0.0179
35 NEONATAL HEPATOMEGALY 1 0.0179
36 BRONCHIAL INJURY 1 0.0172
37 RENAL INTERSTITIAL FIBROSIS 1 0.0169
38 DEATH NEONATAL 23 0.0165
39 SEPSIS NEONATAL 13 0.0160
40 CHEST WALL RIGIDITY 1 0.0156
41 CENTRAL NERVOUS SYSTEM INJURY 1 0.0154
42 CEREBRAL HAEMORRHAGE NEONATAL 3 0.0142
43 PULMONARY PNEUMATOCELE 1 0.0141
44 CYSTIC LUNG DISEASE 2 0.0141
45 NEONATAL HYPOTENSION 5 0.0136
46 MECHANICAL VENTILATION COMPLICATION 2 0.0134
47 NEONATAL RESPIRATORY ACIDOSIS 2 0.0132
48 PNEUMOPERICARDIUM 2 0.0116
49 NEONATAL CARDIAC FAILURE 1 0.0111
50 NEONATAL DYSPNOEA 1 0.0105
51 PULMONARY HAEMORRHAGE 78 0.0100
52 RENAL IMPAIRMENT NEONATAL 1 0.0099
53 ATELECTASIS NEONATAL 1 0.0093
54 VERTICAL INFECTION TRANSMISSION 1 0.0088
55 INFANTILE APNOEIC ATTACK 2 0.0085
56 NEONATAL ASPHYXIA 6 0.0085
57 ANAEMIA NEONATAL 4 0.0083
58 PRODUCT GEL FORMATION 1 0.0082
59 NEONATAL HYPONATRAEMIA 1 0.0082
60 BACILLUS INFECTION 5 0.0079
61 THROMBOCYTOPENIA NEONATAL 3 0.0071
62 PERIVENTRICULAR LEUKOMALACIA 2 0.0071
63 HYPOTHERMIA NEONATAL 1 0.0070
64 TRACHEAL OEDEMA 1 0.0068
65 PULMONARY AIR LEAKAGE 1 0.0066
66 PERSISTENT FOETAL CIRCULATION 4 0.0066
67 NEONATAL TACHYCARDIA 1 0.0065
68 IMMATURE RESPIRATORY SYSTEM 1 0.0064
69 CONGENITAL GENITAL MALFORMATION 1 0.0063
70 ULTRASOUND ABDOMEN ABNORMAL 1 0.0062
71 OXYGEN SATURATION INCREASED 2 0.0059
72 NEONATAL INFECTION 2 0.0058
73 NEONATAL DISORDER 9 0.0057
74 NEONATAL RESPIRATORY DISTRESS SYNDROME 18 0.0051
75 MECONIUM ASPIRATION SYNDROME 1 0.0047
76 NECROTISING COLITIS 6 0.0047
77 RENAL CORTICAL NECROSIS 1 0.0043
78 SUBCUTANEOUS EMPHYSEMA 4 0.0041
79 DEPENDENCE ON OXYGEN THERAPY 2 0.0041
80 NEONATAL SEIZURE 1 0.0040
81 APNOEIC ATTACK 2 0.0035
82 INTRAVENTRICULAR HAEMORRHAGE 8 0.0032
83 NEONATAL RESPIRATORY DISTRESS 3 0.0032
84 NEONATAL ASPIRATION 1 0.0030
85 HYPERCAPNIA 9 0.0030
86 PULMONARY NECROSIS 1 0.0029
87 PNEUMONITIS CHEMICAL 1 0.0029
88 WEANING FAILURE 1 0.0027
89 CLONIC CONVULSION 2 0.0027
90 MEDIASTINAL DISORDER 1 0.0027
91 BRONCHOPLEURAL FISTULA 1 0.0027
92 FOETAL GROWTH RETARDATION 2 0.0026
93 NEONATAL TACHYPNOEA 1 0.0024
94 RESUSCITATION 4 0.0024
95 PNEUMOTHORAX 37 0.0023
96 REFLUX LARYNGITIS 1 0.0023
97 FEEDING INTOLERANCE 1 0.0022
98 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 1 0.0021
99 JAUNDICE NEONATAL 4 0.0021
100 OXYGEN CONSUMPTION INCREASED 5 0.0021
101 RESPIRATORY DISORDER NEONATAL 3 0.0018
102 INTERLEUKIN LEVEL INCREASED 1 0.0018
103 ENDOTRACHEAL INTUBATION 5 0.0018
104 RESPIRATORY TRACT HAEMORRHAGE 1 0.0017
105 OXYGEN CONSUMPTION DECREASED 1 0.0017
106 PNEUMOPERITONEUM 3 0.0016
107 PRODUCT COMPLAINT 40 0.0016
108 APGAR SCORE LOW 2 0.0016
109 PNEUMONIA NECROTISING 1 0.0015
110 ENTEROCOCCUS TEST POSITIVE 1 0.0015
111 VULVAL DISORDER 1 0.0015
112 ILEAL PERFORATION 1 0.0015
113 CEREBRAL CYST 1 0.0015
114 ANAEMIA MACROCYTIC 3 0.0014
115 CATHETER SITE RELATED REACTION 1 0.0013
116 COAGULATION TEST ABNORMAL 1 0.0013
117 PRODUCT ADMINISTRATION ERROR 26 0.0013
118 LABORATORY TEST INTERFERENCE 1 0.0013
119 PULMONARY HYPOPLASIA 1 0.0013
120 PLACENTAL INSUFFICIENCY 1 0.0012
121 PERFORATION 1 0.0012
122 HYPOGLYCAEMIA NEONATAL 2 0.0012
123 BRADYCARDIA FOETAL 1 0.0012
124 OESOPHAGEAL PERFORATION 1 0.0012
125 OESOPHAGEAL RUPTURE 1 0.0012
126 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
127 BRONCHIOLITIS 4 0.0011
128 PNEUMOMEDIASTINUM 2 0.0011
129 HEPATIC CONGESTION 1 0.0011
130 AGITATION NEONATAL 1 0.0010
131 PRESCRIBED OVERDOSE 20 0.0010
132 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
133 PATENT DUCTUS ARTERIOSUS 4 0.0010
134 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
135 CAPILLARY LEAK SYNDROME 2 0.0010
136 HYPOPERFUSION 1 0.0010
137 PRODUCT SELECTION ERROR 1 0.0009
138 PULMONARY HYPERTENSION 19 0.0009
139 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
140 HYPOCHLORAEMIA 1 0.0009
141 ILL-DEFINED DISORDER 50 0.0008
142 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
143 APNOEA 6 0.0008
144 LUNG OPACITY 2 0.0008
145 GLYCOSURIA 1 0.0007
146 OFF LABEL USE OF DEVICE 1 0.0007
147 CARBON DIOXIDE INCREASED 1 0.0007
148 MUCOUS MEMBRANE DISORDER 1 0.0007
149 RENAL INFARCT 1 0.0007
150 BLOOD PRESSURE IMMEASURABLE 1 0.0007
151 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
152 BRONCHIAL DISORDER 1 0.0006
153 PRODUCT DEPOSIT 1 0.0006
154 HYPOTONIA NEONATAL 1 0.0006
155 FUNGAEMIA 1 0.0006
156 METABOLIC SYNDROME 1 0.0006
157 BLOOD PH DECREASED 1 0.0006
158 HYPOPROTEINAEMIA 1 0.0005
159 ADRENAL DISORDER 1 0.0005
160 CARDIOPULMONARY FAILURE 2 0.0005
161 HYPERTRIGLYCERIDAEMIA 3 0.0005
162 EMPYEMA 1 0.0005
163 FOAMING AT MOUTH 1 0.0005
164 HYPOSPADIAS 1 0.0005
165 DILATATION VENTRICULAR 1 0.0005
166 NOSOCOMIAL INFECTION 1 0.0005
167 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
168 CALCINOSIS 1 0.0004
169 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
170 OXYGEN SATURATION DECREASED 24 0.0004
171 DRUG ADMINISTRATION ERROR 13 0.0004
172 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
173 EXCORIATION 1 0.0004
174 INCREASED BRONCHIAL SECRETION 1 0.0004
175 PRODUCT COLOUR ISSUE 2 0.0004
176 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
177 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
178 OXYGEN SATURATION ABNORMAL 1 0.0004
179 HAEMOTHORAX 1 0.0003
180 PREMATURE BABY 10 0.0003
181 NO THERAPEUTIC RESPONSE 4 0.0003
182 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
183 SKIN INJURY 1 0.0003
184 REGURGITATION 1 0.0003
185 DEVICE OCCLUSION 4 0.0003
186 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
187 INTESTINAL PERFORATION 3 0.0003
188 SHOCK 6 0.0003
189 TRICUSPID VALVE INCOMPETENCE 2 0.0003
190 EXPOSURE VIA BREAST MILK 1 0.0003
191 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
192 CIRCULATORY COLLAPSE 4 0.0002
193 POOR PERIPHERAL CIRCULATION 1 0.0002
194 URINE OUTPUT DECREASED 2 0.0002
195 PULMONARY FUNCTION TEST DECREASED 1 0.0002
196 UNDERDOSE 16 0.0002
197 METABOLIC ACIDOSIS 7 0.0002
198 ISCHAEMIA 1 0.0002
199 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
200 BRONCHOSPASM 3 0.0002
201 ACUTE RESPIRATORY FAILURE 4 0.0002
202 RENAL TUBULAR NECROSIS 2 0.0002
203 APPLICATION SITE BURN 1 0.0002
204 STAPHYLOCOCCAL SEPSIS 1 0.0002
205 EXPIRED DRUG ADMINISTERED 1 0.0002
206 SMALL FOR DATES BABY 1 0.0002
207 HYPERNATRAEMIA 1 0.0002
208 PRODUCT QUALITY ISSUE 27 0.0002
209 EMPHYSEMA 2 0.0002
210 KLEBSIELLA INFECTION 1 0.0002
211 DYSPHORIA 1 0.0002
212 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
213 DERMATITIS 4 0.0002
214 HYDROCEPHALUS 1 0.0002
215 ASPIRATION 2 0.0002
216 COAGULOPATHY 3 0.0002
217 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
218 HAEMOPTYSIS 5 0.0002
219 ANGIOPATHY 1 0.0002
220 VENTRICULAR SEPTAL DEFECT 1 0.0002
221 METABOLIC DISORDER 1 0.0002
222 RALES 1 0.0002
223 ELECTROLYTE IMBALANCE 2 0.0002
224 HEART RATE DECREASED 6 0.0002
225 BRADYCARDIA 9 0.0002
226 PROTHROMBIN TIME PROLONGED 1 0.0002
227 FOETAL GROWTH RESTRICTION 1 0.0002
228 PIGMENTATION DISORDER 1 0.0002
229 OLIGURIA 1 0.0002
230 BLOOD SODIUM DECREASED 3 0.0002
231 APPLICATION SITE VESICLES 1 0.0002
232 RESPIRATORY FAILURE 11 0.0002
233 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
234 TACHYPNOEA 2 0.0001
235 PERITONITIS 3 0.0001
236 CEREBRAL HAEMORRHAGE 5 0.0001
237 HYPERGLYCAEMIA 5 0.0001
238 ASCITES 4 0.0001
239 HYPOPHOSPHATAEMIA 1 0.0001
240 HAEMODYNAMIC INSTABILITY 1 0.0001
241 ACIDOSIS 1 0.0001
242 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
243 PROCEDURAL COMPLICATION 1 0.0001
244 CYANOSIS 2 0.0001
245 LOW BIRTH WEIGHT BABY 1 0.0001
246 DRUG LEVEL INCREASED 2 0.0001
247 EXPIRED PRODUCT ADMINISTERED 4 0.0001
248 PSEUDOMONAS INFECTION 1 0.0001
249 ANURIA 1 0.0001
250 RASH GENERALISED 3 0.0001
251 LUNG INFILTRATION 1 0.0001
252 RESPIRATORY RATE INCREASED 1 0.0001
253 PALLOR 3 0.0001
254 HYPOTONIA 1 0.0001
255 BRAIN INJURY 1 0.0001
256 PERITONITIS BACTERIAL 1 0.0001
257 HYPOTHERMIA 1 0.0001
258 HYPERBILIRUBINAEMIA 1 0.0001
259 OFF LABEL USE 84 0.0001
260 TRANSFUSION 1 0.0001
261 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
262 DECREASED ACTIVITY 1 0.0001
263 PRODUCT DISPENSING ERROR 2 0.0001
264 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
265 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
266 CAESAREAN SECTION 1 0.0001
267 HYPOXIA 3 0.0001
268 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
269 C-REACTIVE PROTEIN INCREASED 3 0.0001
270 RESPIRATORY DEPRESSION 1 0.0001
271 GENERALISED OEDEMA 1 0.0001
272 ANAPHYLACTIC SHOCK 2 0.0001
273 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
274 PERIPHERAL COLDNESS 1 0.0001
275 CARDIAC ARREST 6 0.0001
276 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
277 HYPOMAGNESAEMIA 1 0.0001
278 CARDIO-RESPIRATORY ARREST 3 0.0001
279 HAEMORRHAGE INTRACRANIAL 1 0.0001
280 RESPIRATORY DISORDER 2 0.0001
281 SKIN DISCOLOURATION 3 0.0001
282 PREMATURE DELIVERY 1 0.0001
283 BLOOD CREATININE INCREASED 4 0.0001
284 LUNG DISORDER 3 0.0001
285 LEUKOPENIA 3 0.0001
286 BLOOD UREA INCREASED 1 0.0001
287 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
288 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
289 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
290 MULTI-ORGAN FAILURE 1 0.0001
291 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
292 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
293 BACTERIAL INFECTION 1 0.0001
294 HYPOCALCAEMIA 1 0.0001
295 PULMONARY FIBROSIS 1 0.0001
296 CHOLESTASIS 1 0.0001
297 CHOKING 1 0.0001
298 HAEMATOCRIT DECREASED 1 0.0001
299 CARDIAC FAILURE 4 0.0000
300 PRODUCT PHYSICAL ISSUE 1 0.0000
301 RIB FRACTURE 1 0.0000
302 ABDOMINAL DISTENSION 5 0.0000
303 OVERDOSE 10 0.0000
304 CONDITION AGGRAVATED 14 0.0000
305 PRODUCT AVAILABILITY ISSUE 1 0.0000
306 INTERSTITIAL LUNG DISEASE 2 0.0000
307 LIVER INJURY 1 0.0000
308 UNEVALUABLE EVENT 3 0.0000
309 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
310 JAUNDICE 1 0.0000
311 BLOOD BILIRUBIN INCREASED 1 0.0000
312 PNEUMONITIS 1 0.0000
313 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
314 RESPIRATORY ARREST 1 0.0000
315 RESPIRATORY DISTRESS 1 0.0000
316 ANAPHYLACTIC REACTION 2 0.0000
317 MEDICATION ERROR 2 0.0000
318 SEPSIS 4 0.0000
319 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
320 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
321 DRUG INEFFECTIVE 46 0.0000
322 HEPATIC FAILURE 1 0.0000
323 ACUTE KIDNEY INJURY 5 0.0000
324 NERVOUS SYSTEM DISORDER 1 0.0000
325 PRODUCT USE ISSUE 6 0.0000
326 BLOOD PRESSURE DECREASED 2 0.0000
327 SKIN DISORDER 1 0.0000
328 HYPOTENSION 6 0.0000
329 NEUTROPENIA 4 0.0000
330 HYPERKALAEMIA 1 0.0000
331 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
332 NO ADVERSE EVENT 5 0.0000
333 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
334 RESTLESSNESS 1 0.0000
335 THROMBOCYTOPENIA 3 0.0000
336 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
337 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
338 SEPTIC SHOCK 1 0.0000
339 GASTROINTESTINAL DISORDER 2 0.0000
340 PNEUMONIA 7 0.0000
341 RENAL DISORDER 1 0.0000
342 SWELLING 2 0.0000
343 PRODUCTIVE COUGH 1 0.0000
344 RASH ERYTHEMATOUS 1 0.0000
345 INFECTION 3 0.0000
346 FLUID RETENTION 1 0.0000
347 ERYTHEMA 4 0.0000
348 BLISTER 1 0.0000
349 DYSPNOEA 10 0.0000
350 FLATULENCE 1 0.0000
351 DEEP VEIN THROMBOSIS 1 0.0000
352 DEVICE MALFUNCTION 1 0.0000
353 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
354 INCORRECT DOSE ADMINISTERED 3 0.0000
355 INJECTION SITE SWELLING 1 0.0000
356 DEATH 11 0.0000
357 TREATMENT FAILURE 1 0.0000
358 RENAL IMPAIRMENT 1 0.0000
359 PRODUCT STORAGE ERROR 1 0.0000
360 DRUG WITHDRAWAL SYNDROME 1 0.0000
361 TACHYCARDIA 1 0.0000
362 DEVICE ISSUE 1 0.0000
363 ADVERSE DRUG REACTION 1 0.0000
364 CARDIAC DISORDER 1 0.0000
365 ANAEMIA 2 0.0000
366 DRUG INTOLERANCE 1 0.0000
367 HEART RATE INCREASED 1 0.0000
368 CHEST DISCOMFORT 1 0.0000
369 HAEMOGLOBIN DECREASED 1 0.0000
370 HAEMORRHAGE 1 0.0000
371 HYPERTENSION 2 0.0000
372 PLATELET COUNT DECREASED 1 0.0000
373 MALAISE 4 0.0000
374 SEIZURE 1 0.0000
375 DISEASE PROGRESSION 1 0.0000
376 RENAL FAILURE 1 0.0000
377 DEHYDRATION 1 0.0000
378 TREMOR 1 0.0000
379 TOXICITY TO VARIOUS AGENTS 1 0.0000
380 MYOCARDIAL INFARCTION 1 0.0000
381 HYPERSENSITIVITY 1 0.0000
382 WEIGHT INCREASED 1 0.0000
383 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
384 PYREXIA 1 0.0000